-
Invokana / Jardiance / Farxiga: Increased Risks Of Lower-Limb Amputations Compared To Another Class Of Diabetes Drugs
Today Only The Invokana Drug Label Includes Warnings About Amputations Of Legs, Feet, And Toes; Will There Be Label Changes For Farxiga And Jardiance? (Posted by Tom Lamb at DrugInjuryWatch.com) Another new…
-
Diabetes Drug Tradjenta Associated With Bullous Pemphigoid, A Chronic Blistering Skin Condition
Bullous Pemphigoid (BP) Is An Auto-Immune Skin Disease Which Can Be Fatal, Particularly In Patients Who Are Debilitated (Posted by Tom Lamb at DrugInjuryWatch.com) Three relatively new medical studies add weight to…
-
Some Newer Diabetes Drugs Linked To Lower Limb Amputations: “Significantly Increased Risk”
New Study Suggests Possible Drug Class Side Effects Of SGLT-2 Inhibitors Such As Invokana, Jardiance, And Farxiga (Posted by Tom Lamb at DrugInjuryWatch.com) Sodium-glucose cotransporter 2 inhibitors (SGLT-2 inhibitors) are relatively new…
-
Actemra Side Effects: Pulmonary Hypertension, Interstitial Lung Disease, Pulmonary Alveolar Proteinosis
FDA Watch List Includes Actemra: Evaluating Regulatory Action Based On Possible Signs Of Serious Risk, New Safety Information (Posted by Tom Lamb at DrugInjuryWatch.com) In July 2018 the FDA issued this document,…
-
Bayer: Essure Permanent Birth Control Device Removal From US Market Is “Business Decision”
Or Is This Really An Essure Recall Due To High Numbers Of Adverse Events Reported To FDA And Related Essure Lawsuits (Posted by Tom Lamb at DrugInjuryWatch.com) We have reported developments concerning…
-
Pradaxa-Related Liver Injury: Health Canada’s Drug Safety Review Of Pradaxa Concludes There Is A Link
Remains Unknown Whether Pradaxa Label Change About Liver Damage In Canada Will Be Followed By Similar FDA Action In US (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2018 Health Canada announced…